091440 — Hanwool Materials Science Balance Sheet
0.000.00%
- KR₩74bn
- KR₩139bn
- KR₩17bn
Annual balance sheet for Hanwool Materials Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 22,644 | 8,854 | 521 | 9,706 | 19,793 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9,562 | 12,102 | 3,588 | 7,713 | 5,328 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 49,852 | 34,713 | 18,141 | 29,139 | 43,346 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,158 | 5,490 | 17,419 | 11,919 | 52,752 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 62,449 | 47,467 | 44,764 | 42,929 | 129,216 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 31,904 | 26,163 | 20,343 | 14,806 | 25,645 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 41,852 | 33,206 | 28,213 | 20,904 | 87,430 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 20,598 | 14,261 | 16,551 | 22,025 | 41,786 |
| Total Liabilities & Shareholders' Equity | 62,449 | 47,467 | 44,764 | 42,929 | 129,216 |
| Total Common Shares Outstanding |